Johnson & Johnson’s Stelara, Regeneron’s Eylea and Amgen’s Prolia are just some of the drugs facing off against new ...
With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...
Global drugmaker Novartis will lay off 427 employees who report to the company's East Hanover headquarters this spring and summer, after it let go of 235 at the Morris County site last year, filings ...
Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...
On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...
The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...
Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...
Daily Voice on MSN5d
Pharma Giant Cutting 400+ More East Hanover Jobs Ahead Of Major Drug Patent's ExpirationPharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...
GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback